Thank you
This live web event has ended. Thank you for attending.
Description
Liquid Biopsy and Concurrent
Testing Strategies for Patients
with Metastatic NSCLC
Why should you register now for this webinar?
- Hear a national thought leader discuss the impact of liquid biopsy and concurrent biomarker testing for the appropriate care of patients with NSCLC
- Brought to you by: CAP TODAY
- Moderated by: Bob McGonnagle, Publisher, CAP TODAY
- Presenter: Zin Htway, PhD
What will this webinar empower you to do?
- Review the potential benefits of integrating liquid biopsy with standard-of-care tissue testing on turnaround time and identification of patients with actionable biomarkers in metastatic NSCLC
- Explore patient case scenarios that demonstrate potential successes and implementation considerations for concurrent liquid biopsy integration in metastatic NSCLC
CAP TODAY does not endorse any of the products or services named within. This webinar is sponsored by AstraZeneca in partnership with OncoLens.